Sirtris and Harvard Discover New Mechanism to Slow Aging: CMS Optimal Dose Soon To Follow

by: |
09/20/2007

We don't want people living too long now, do we? Not cost-effective. Thank goodness we have the know it alls at CMS who can quickly come up with the optimal lifespan. Once you have the optimal dose for ESAs down pat why stop there? Something for Herb Kuhn and co to think about as they defend their decision and peddle their brilliance to congressional staff in the weeks ahead....

http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20070920005089&newsLang=en

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Sirtris and Harvard Discover New Mechanism to Slow Aging: CMS Optimal Dose Soon To Follow

Latest from CMPI

Coronavirus: America’s drug supply needs a refill

Prescription for Failure: The Ills of Socialized Medicine (CPAC 2020)

How to eliminate surprise medical bills

Keep Canadian drugs out of U.S. medicine cabinets

Blog Roll

Categories